Acadian Asset Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Acadian Asset Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.37M	Buy	45,942 +38,401	+509%	+$1.27M	﹤0.01%	1072
2025 Q4	$246K	Buy	+7,541	New	+$243K	﹤0.01%	1476
2024 Q3	–	Sell	-844	Closed	-$20K	–	2182
2024 Q2	$20K	Sell	844 -14,342	-94%	-$407K	﹤0.01%	1679
2024 Q1	$488K	Buy	15,186 +2,366	+18%	+$88K	﹤0.01%	1011
2023 Q4	$520K	Sell	12,820 -6,329	-33%	-$233K	﹤0.01%	1020
2023 Q3	$661K	Buy	19,149 +12,154	+174%	+$473K	﹤0.01%	941
2023 Q2	$284K	Buy	6,995 +3,722	+114%	+$152K	﹤0.01%	1193
2023 Q1	$126K	Buy	+3,273	New	+$135K	﹤0.01%	1348
2022 Q2	–	Sell	-412	Closed	-$25K	–	1742
2022 Q1	$25K	Buy	+412	New	+$25.2K	﹤0.01%	1548
2021 Q2	–	Sell	-14,087	Closed	-$1.09M	–	2076
2021 Q1	$1.09M	Buy	+14,087	New	+$1.3M	﹤0.01%	930
2020 Q4	–	Sell	-39,725	Closed	-$5.64M	–	2258
2020 Q3	$5.64M	Sell	39,725 -29,657	-43%	-$4.94M	0.02%	414
2020 Q2	$13.7M	Sell	69,382 -4,744	-6%	-$983K	0.06%	275
2020 Q1	$14.5M	Buy	74,126 +28,146	+61%	+$6.06M	0.08%	204
2019 Q4	$9.51M	Buy	+45,980	New	+$8.5M	0.04%	319
2017 Q3	–	Sell	-2,173	Closed	-$166K	–	1446
2017 Q2	$166K	Buy	+2,173	New	+$183K	﹤0.01%	969
2017 Q1	–	Sell	-11,810	Closed	-$758K	–	1638
2016 Q4	$758K	Buy	+11,810	New	+$727K	﹤0.01%	772

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management's LKFT Position: Q1 2026 in Review

Acadian Asset Management increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 509% in Q1 2026, buying an estimated $1.27M and bringing the position to 45,942 shares worth $1.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1072.

Acadian Asset Management first reported a position in LKFT in Q4 2016 and has held it in 16 quarters since. The position peaked at $14.5M in Q1 2020. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

Acadian Asset Management held 45,942 shares of Lakefront Biotherapeutics American Depositary Shares worth $1.37M as of Q1 2026.
Acadian Asset Management bought 38,401 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $1.27M.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1072 holding.
Acadian Asset Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2016 and has held it in 16 quarters since.
Acadian Asset Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $14.5M in Q1 2020.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.